0%
Evolving Standards in Cancer Care: From Evidence to Action led by Program Director Dr. Satheesh C T (HCG Cancer Hospital).
Excellence in Oncology Series 12 is a premier educational webinar led by Program Director Dr. Satheesh C T (Senior Consultant & Professor Medical Oncology, HCG Cancer Hospital, Bengaluru). Theme: 'Evolving Standards in Cancer Care: From Evidence to Action'. Program features sessions on Immunotherapy in Endometrial Cancer (Dr. Kaushik M R), ENHERTU + Pertuzumab in 1L HER2+ Metastatic Breast Cancer, CROWN trial in ALK NSCLC (Dr. Ravi T), PH & TDM1 in HER2+ Breast Cancer (Dr. Karthik Udupa), Atezolizumab + Bevacizumab in Intermediate HCC, and ENHERTU in HR+ HER2-low Metastatic Breast Cancer.
The primary aim of Excellence in Oncology Series 12 is to deliver updated, evidence-based scientific insights into multidisciplinary breast cancer care, advanced immunotherapy, HER2-targeted agents, and surgical management. The program seeks to foster multidisciplinary collaboration among clinical specialists, enhance diagnostic accuracy, and translate groundbreaking clinical trial data into daily clinical practice.
The program was conducted as a structured virtual webinar & interactive online forum. The scientific agenda comprised keynote lectures by distinguished domain experts, case-based panel discussions on complex clinical scenarios, interactive Q&A sessions, and comprehensive reviews of landmark clinical trials in Breast Oncology.
The conference successfully equipped participating healthcare professionals with practical strategies for optimizing clinical decision-making in Breast Oncology. By establishing updated treatment algorithms and promoting collaborative care networks, the event reinforces commitment to improving patient survival rates and quality of life.